Trends in Glycemia Risk Index Over Time in Patients With Diabetes and Cancer Undergoing Remote Continuous Glucose Monitoring
Authors' conclusion
Sequential CGM review was associated with improved glycemic quality in adults with diabetes and cancer. Remote CGM achieved glycemic outcomes comparable with nonremote review
Study context
- Population
- Adults (≥18 years) with diabetes and cancer at a comprehensive cancer center in 2024, ≥2 continuous glucose monitoring (CGM) assessments (≥1 remote CGM (RCGM)) and baseline glucose management indicator (GMI) or HbA1c ≥8.0%; mean age 60.2 ± 10.6 years, 95% T2D
- Participants
- 42 adults
- Exposure
- Remote CGM vs nonremote review; trend over sequential CGM assessments
- Outcome
- GRI, GMI, average glucose, TIR, TAR, TBR across sequential assessments and by RCGM use
Methodological detailsretrospective chart review, single comprehensive cancer center, pre-specified noninferiority margins (conservative and liberal)
- Retrospective chart review
- Single comprehensive cancer center
- Pre-specified noninferiority margins (conservative and liberal)
Main finding
As reported in the abstract
- Across sequential assessments, Glycemia Risk Index (GRI), GMI, average glucose and time above range (TAR) decreased, time in range (TIR) increased
- all P < .05
Observational data: associations, not effects.
Further findings
Baseline CGM metrics
- Mean GRI
- 70 ± 27
- GMI
- 8.5% ± 1.1%
- Average glucose
- 214 ± 46 mg/dL
- TIR
- 38% ± 21%
- TAR
- 61% ± 21%
- Time below range (TBR)
- 1% ± 1%
Original publication
Trends in Glycemia Risk Index Over Time in Patients With Diabetes and Cancer Undergoing Remote Continuous Glucose Monitoring. J Diabetes Sci Technol. Published 23 July 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →